Skip to main content

Table 2 Process times for patients who became symptomatic before first blood sampling or before the first screening result was available

From: Efficacy and outcome of expanded newborn screening for metabolic diseases - Report of 10 years from South-West Germany *

Diagnosis Age at decom-pensation
(days)
Age at blood samp-ling 1st screening card (days) Age at 1st screening result (days) Age at con-firmed diagnosis (days) Age at start of treatment (days)
MCADD 0.0 4.0 11.0 12.0 14.0
MCADD 3 1.7 6.8 6.0 3.0
CIT I classic 1.0 3.0 12.0 2.0 2.0
CIT I classic 1.0 3.0 10.0 5.0 Not available
CIT I classic 2.0 2.7 8.6 2.0 2.0
IVA classic 3.0 4.4 10.7 8.0 8.0
PA 3.0 3.0 16.0 3.0 3.0
Cobalamin C/D defect 3.0 5.0 15.0 5.0 5.0
Galactosaemia 4.0 3.5 7.0 8.0 7.0
Galactosaemia 8.0 4.2 11.1 9.0 9.0
MSUD 4.0 3.4 9.3 5.0 5.0
  1. Abbreviations see Table 1
  2. Bold text indicates that the first screening result arrived after confirmed diagnosis.